Strengthening Polymer Design and Modification Technologies and Nanotechnology
First written in FY2016. 25 of 28 entries say "Restated". Latest entry: FY2026.
51 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Research and development expenses for the current consolidated fiscal year were ¥3,240 million, including ¥997 million in expenses for company-wide research themes conducted at the General Research Laboratory that cannot be allocated to individual business divisions.」
The company recorded ¥3,240 million in research and development expenses and advanced the development and expansion of applications for Uniamid, Unifiner, Zecot, Nanocon, recycled resins, ultra-ultrathin glass cloth and hollow-fiber membranes, among other products. - FY2026-H1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the current interim consolidated accounting period was ¥1,618 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and disclosed interim-period research and development expenses of ¥1,618 million. - FY2025-H1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the current interim consolidated accounting period was ¥1,628 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥1,628 million in research and development expenses and stated that there were no material changes in the status of its research and development activities. - FY2024-Q2RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥1,835 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥1,835 million in research and development expenses and stated that there were no material changes in the status of its research and development activities. - FY2024-Q1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥881 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥881 million in research and development expenses and stated that there were no material changes in the status of its research and development activities. - FY2023AdvancedAnnual report
「Research and development expenses for the current consolidated fiscal year were ¥3,757 million, including ¥1,299 million in expenses for company-wide research themes conducted at the Central Research Laboratory that cannot be allocated to individual business divisions.」
The company recorded ¥3,757 million in research and development expenses and provided specific details on the development and expansion of applications for Uniamid, Unifiner, Zecot, Nanocon and nylon 6 incorporating cellulose nanofibers, among other products. - FY2023-Q3RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥2,788 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥2,788 million in research and development expenses and stated that there were no material changes in the status of its research and development activities. - FY2023-Q2RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥1,818 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥1,818 million for the second quarter of the current consolidated cumulative period. - FY2023-Q1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥865 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥865 million in research and development expenses and stated that there were no material changes in the status of its research and development activities. - FY2022-Q3RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥2,675 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and that research and development expenses for the third quarter of the current consolidated cumulative period were ¥2,675 million. - FY2022-Q2RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥1,784 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥1,784 million for the second quarter of the current consolidated cumulative period. - FY2022-Q1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥710 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥710 million for the first-quarter cumulative period. - FY2021-Q3RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥2,684 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥2,684 million for the third quarter of the current consolidated cumulative period. - FY2021-Q2RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥1,832 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥1,832 million in research and development expenses and stated that there were no material changes in the status of its research and development activities. - FY2021-Q1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥863 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥863 million for the first-quarter cumulative period. - FY2020RestatedAnnual report
「Regarding research and development, the company will develop and deepen the core technologies held by the Group, including polymerization, materials design and polymer processing, while continuing to strengthen its proprietary structure-control technologies and accelerating the development of products that will drive growth, including next-generation films, high-performance resins and fibers.」
The company continues to pursue its policy of strengthening its core technologies and structure-control technologies and accelerating the development of next-generation films, high-performance resins and fibers. Research and development expenses were ¥3,624 million. - FY2020-Q3RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥2,731 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥2,731 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2020-Q2RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥1,831 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥1,831 million for the current second-quarter cumulative period. - FY2020-Q1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥872 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥872 million for the quarter. - FY2019-Q3RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥2,586 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥2,586 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2019-Q2RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥1,752 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥1,752 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2019-Q1RestatedAnnual report
「The amount of research and development activities conducted by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥854 million. There were no material changes in the status of the Group's research and development activities during the period.」
The company recorded ¥854 million in research and development expenses and stated that there were no material changes in its research and development activities. - FY2018RestatedAnnual report
「In research and development, the Company will make effective use of management resources to develop and deepen the Group's core technologies, including polymerization and material design, polymer modification and processing, while further strengthening proprietary structure-control technologies and accelerating the development of products that will drive growth, such as high-performance films and resins, high-heat-resistance films, and high-performance nonwoven fabrics and fibers.」
The Company continues to prioritize its core research and development technologies and the accelerated development of growth products. Research and development expenses for the fiscal year were ¥3,274 million. - FY2018-Q2RestatedAnnual report
「The Group's research and development activities totaled ¥1,709 million during the cumulative first two quarters. There were no material changes in the status of the Group's research and development activities during the cumulative first two quarters.」
The Company recorded research and development expenses of ¥1,709 million and stated that there were no material changes in its research and development activities. - FY2017-Q3RestatedAnnual report
「The Group's research and development activities totaled ¥2,323 million during the cumulative first three quarters. There were no material changes in the status of the Group's research and development activities during the cumulative first three quarters.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥2,323 million for the cumulative first three quarters. - FY2017-Q2RestatedAnnual report
「The Group's research and development activities totaled ¥1,527 million during the cumulative first two quarters. There were no material changes in the status of the Group's research and development activities during the cumulative first two quarters.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥1,527 million for the cumulative first two quarters. - FY2017-Q1RestatedAnnual report
「The Group's research and development activities totaled ¥766 million during the cumulative first quarter. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The Company stated that there were no material changes in its research and development activities and reported research and development expenses of ¥766 million for the first quarter. - FY2016First statedAnnual report
「The Group will further strengthen its polymer design and modification technologies, proprietary nanotechnology and other capabilities, and accelerate development of high-performance resins, high-heat-resistance films, high-performance fibers and other products that will drive growth.」
Research and development expenses for the fiscal year were ¥3,203 million. Each business is working to commercialize new products, expand their adoption track record and develop applications.